Keywords: Sanofi-Aventis, Joint venture, Japan, Generics, Minority stake, Nichi-Iko

Sanofi-Aventis makes foray into Japan’s generics market via a JV and minority stake in Nichi-Iko Pharma

Article | 28 May 2010

Print This

Confirming both the drug major’s diversification strategy and recent rumors of an acquisition in the Japanese generics market, France’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in